Group A Rotavirus Veterinary Vaccines
Key result
Genetically engineered rotavirus-like particle vaccines and maternal vaccination strategies show promise for preventing group A rotavirus diarrhea in young livestock and poultry.
Population
Young livestock and poultry, including gnotobiotic pigs, calves, and cows
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May guide maternal and VLP strategies in livestock; leaves open confirmation via controlled field trials before practice change.
Structured PICO
P
Population
Young livestock and poultry, including gnotobiotic pigs, calves, and cows
I
Intervention
Group A rotavirus veterinary vaccines (including live attenuated, maternal, and genetically engineered rotavirus-like particle vaccines)
O
Outcome
Induction of active or passive immunity
Genetically engineered rotavirus-like particle vaccines show promise as subunit vaccines to boost lactogenic immunity in livestock, potentially overcoming the limitations of live attenuated vaccines.
Limitations
- Live attenuated rotavirus vaccines lacked efficacy when administered orally due to colostral antibodies.
- Variable success of maternal rotavirus vaccines is influenced by multiple factors including dose, strain, and environmental exposure.
Cite This Study
Saif et al. (1996) conducted a review in Group A rotavirus infection in livestock and poultry. Group A rotavirus veterinary vaccines was evaluated. Genetically engineered rotavirus-like particle vaccines and maternal vaccination strategies show promise for preventing group A rotavirus diarrhea in young livestock and poultry.